Aaron Cowen’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-500,000
Closed -$3.09M – 91
2026
Q2
$3.09M Sell
500,000
-2,176,000
-81% -$11.9M 0.06% 71
2026
Q1
$12M Hold
2,676,000
– – 0.31% 47
2025
Q4
$14.1M Hold
2,676,000
– – 0.29% 59
2025
Q3
$14.1M Hold
2,676,000
– – 0.36% 59
2025
Q2
$15.2M Sell
2,676,000
-1,009,503
-27% -$5.75M 0.46% 50
2025
Q1
$17.5M Hold
3,685,503
– – 0.65% 41
2024
Q4
$20.5M Hold
3,685,503
– – 0.7% 44
2024
Q3
$23.3M Hold
3,685,503
– – 0.75% 44
2024
Q2
$15.6M Buy
+3,685,503
New +$18.8M 0.57% 44

Other funds holding ABEO

Aaron Cowen's ABEO Position: Q3 2026 in Review

Aaron Cowen sold out of Abeona Therapeutics (ABEO) in Q3 2026, closing a stake of 500,000 shares — an estimated $3.09M sold.

Aaron Cowen first reported a position in ABEO in Q2 2024 and held it in 9 quarters. The position peaked at $23.3M in Q3 2024. 115 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Aaron Cowen reported no remaining Abeona Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Aaron Cowen sold 500,000 Abeona Therapeutics shares in Q3 2026, an estimated $3.09M.
  • Aaron Cowen first reported a position in Abeona Therapeutics in Q2 2024 and held it in 9 quarters.
  • Aaron Cowen's Abeona Therapeutics position peaked at $23.3M in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.